Generated: September 20, 2017
DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 205832
, which is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the OFEV profile page.
The generic ingredient in OFEV is nintedanib esylate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the nintedanib esylate profile page.
Summary for NDA: 205832
|Formulation / Manufacturing:||see details|
Pharmacology for NDA: 205832
Complete Access Available with Subscription
Summary for product number 001
|Active Rx/OTC/Discontinued:||RX||Dosage:||CAPSULE;ORAL||Strength||EQ 100MG BASE|
|Approval Date:||Oct 15, 2014||TE:||RLD:||Yes|
|Regulatory Exclusivity Expiration:||Oct 15, 2019
|Regulatory Exclusivity Use:||NEW CHEMICAL ENTITY|
|Regulatory Exclusivity Expiration:||Oct 15, 2021
|Regulatory Exclusivity Use:||ORPHAN DRUG EXCLUSIVITY|
|Patent:||► Subscribe||Patent Expiration:||Dec 10, 2020||Product Flag?||Y||Substance Flag?||Y||Delist Request?|| |
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.